您要查找的是不是：
- Methods 64 patients with advanced breast cancer were divided into two groups: CTX, ADM and 5-Fu/CF c. i. 方法将64例晚期乳腺癌患者采用信封抽签法随机分组;CTX、ADM联合CF+5-Fu持续滴注方案为观察组;CAF方案为对照组;平均化疗2.;5个周期。
- Objective To evaluate efficacy and toxicity of THP containing regimen in the treatment of advanced breast cancer. 目的应用吡柔比星为主联合化疗方案治疗晚期乳腺癌,评价其有效性及毒性。
- Objective:To evaluate the effect of neoadjuvant therapy in the treatment of lo-cally advanced breast cancer. 探讨新辅助治疗在局部晚期乳腺癌治疗中的应用。
- This review presents the present state and future prospect of neoadjuvant chemotherapy for advanced breast cancer. 现就新辅助化疗在乳腺癌治疗中的现状及展望作一综述。
- Objective To observe the efficacy and toxicity of advanced breast cancer treated with Navelbine(NVB)+Cisplatin(DDP). 目的观察长春瑞滨(NVB)、联合顺铂(DDP)治疗晚期乳腺癌的疗效和毒副反应。
- Objective To study the effect of interventio nal treatment on advanced breast cancer and rec urred breast cancer. 目的研究晚期乳腺癌及术后复发性乳腺癌的介入治疗方法及其临床意义。
- Stephen Merrill, another mathematician at Marquette, recently studies bone marrow transplants in the treatment of advanced breast cancer. 史蒂芬马芮尔是马奎特大学另一位数学家，最近研究治疗晚期乳癌的骨髓移植疗法。
- Objective: To evaluate the efficacy and toxicity of vinorelbin(NVB) combined with cisplatin(DDP) in the treatment of advanced breast cancer. 目的:观察去甲长春花碱(Vinorelbin,NVB)联合顺铂(DDP)方案治疗晚期乳腺癌的疗效及毒性反应。
- Objective: To observe the effect , toxicity and clinical benefit response (CBR) of advanced breast cancer , treated with CTF and NT regimen . 目的:比较CTF方案和NT方案治疗晚期乳腺癌的临床疗效、毒副作用及临床受益反应(clinical benefit response CBR)。
- Aim:To evaluate the results of combination chemotherapy with navelbine(NVB) and cisplatin(DDP) treating patients with advanced breast cancer. 目的:评价国产长春瑞滨(NVB,商品名盖诺)联合顺铂(DDP)治疗晚期转移性乳腺癌的临床疗效和毒副反应。
- Slightly more than 80 percent of the patients had standard locally advanced breast cancer, while 18 percent had the more deadly IBC disease. 80%25多的患者患有标准的局限性进展性乳腺癌，而18%25的患者患有致命性的IBC。
- Objective To evaluate the efficacy and toxicicy of Paclitaxel and adriamycin(TA) in the treatment of advanced breast cancer. 目的观察紫杉醇联合阿霉素(TA)治疗晚期乳腺癌的疗效和不良反应。
- Methods: Among 32 patients with advanced breast cancer 18 patients previously received chemotherapy based on anthracycline,while the others did not. 方法:晚期乳腺癌32例其中包括既往应用蒽环类药物治疗18例,非蒽环类药物化疗14例。
- Conclusions CA regimen is as good as CAF regimen in the management of advanced breast cancer, and the toxicities were lower than CAF regimen. CA方案胃肠道反应较CAF轻。 结论 CA方案与CAF方案均是治疗晚期乳腺癌的较佳方案 ,对晚乳腺癌有较高的缓解率和较低的毒副作用。
- Objective To evaluate the effectiveness of preoperation chemotherapy through ulnar arterial catheter on local advanced breast cancer. 目的:探讨术前尺动脉插管化疗在局部晚期乳腺癌中的治疗作用。
- Objective To compare the efficacy and toxicity of regimen CTX, ADM and continuously intravenous 5-Fu/CF and regimen CAF to treat advanced breast cancer. 目的比较CTX、ADM联合CF+5-Fu持续滴注方案与CAF方案治疗晚期乳腺癌的近期疗效与毒性反应。
- Objective To evaluate the efficacy and toxicity of docetaxel plus pirarubicin(THP) in the neoadjuvant chemotherapy of locally advanced breast cancer(LABC). 目的观察多西他赛联合吡柔比星(THP)治疗局部晚期乳腺癌的近期疗效和毒性反应。
- Methods Seventy-eight cases with advanced breast cancer were studied respectively 37 and 41 patients which were treated with NP and CAF regimen,respectively. 方法78例晚期乳腺癌患者分别接受NP、CAF方案的治疗,病例数分别为37和41,观察疗效和毒副反应。
- Condusions:it was suggested that interventional chemotherapy was one effective method that improved the cure rafe and effect in treatment of locally advanced breast cancer. 结论：介入化疗是一种能提高局部晚期乳腺癌的手术切除率和疗效的有效方法。
- Objective To evaluate the effect and safety of combined therapy of paclitaxel and gemcitabine for anthracycine(ANT)-resistant advanced breast cancer(ABC). 目的观察紫杉醇联合吉西他滨方案治疗蒽环类耐药性晚期乳腺癌的疗效与安全性。
